Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(8%)
Results Posted
40%(2 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
8
67%
Ph phase_1
1
8%
Ph phase_2
1
8%
Ph phase_3
1
8%
Ph phase_4
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)
Other(5)

Detailed Status

unknown5
Completed5
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 31 (8.3%)
Phase 41 (8.3%)
N/A8 (66.7%)

Trials by Status

unknown542%
active_not_recruiting18%
terminated18%
completed542%

Recent Activity

1 active trials
Showing 5 of 12
active_not_recruitingphase_3

Combination Gerotherapeutic Interventions for Healthspan Improvement

NCT07475546
completednot_applicable

Evaluating Clinical Effects of a Spray-Type Bio-absorbable Adhesion Barrier System in Paediatric Patients

NCT05255081
completedphase_2

COVID-19 Anosmia Study

NCT04495816
unknownnot_applicable

Brief Mental Training and Internal Attentional Control

NCT05353231
unknownnot_applicable

Family Procedural Presence

NCT03808350
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07475546Phase 3

Combination Gerotherapeutic Interventions for Healthspan Improvement

Active Not Recruiting
NCT05255081Not Applicable

Evaluating Clinical Effects of a Spray-Type Bio-absorbable Adhesion Barrier System in Paediatric Patients

Completed
NCT04495816Phase 2

COVID-19 Anosmia Study

Completed
NCT05353231Not Applicable

Brief Mental Training and Internal Attentional Control

Unknown
NCT03808350Not Applicable

Family Procedural Presence

Unknown
NCT03117738Phase 1

A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease

Completed
NCT03418077Not Applicable

Post-Exercise Cardiovascular Responses Following Energy Drink Consumption

Completed
NCT02959762Not Applicable

Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)

Unknown
NCT03311321Not Applicable

Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients

Unknown
NCT01972113Not Applicable

Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)

Unknown
NCT03716479Not Applicable

Gum Acacia and Blood Glucose

Completed
NCT01591902Phase 4

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

Terminated

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12